Aurobindo Pharma Limited
AUROPHARMA · 524804 · Healthcare · Pharmaceuticals
- Market cap
- Rs 96,857 Cr
- P/E
- 26.30x
- P/B
- 2.56x
- 52W high / low
- Rs 1,717 / Rs 1,016.1
Our computed operating_margin (16.63%) diverges from BSE's own published figure (35.73%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong. Our computed net_margin (10.62%) diverges from BSE's own published figure (24.84%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.
More
Peer comparison
Official BSE basic industry: Pharmaceuticals. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Sun Pharmaceutical Industries Limited | Rs 1,929 | Rs 4,62,825 Cr | Rs 62,141 Cr | Rs 12,117 Cr | 38.27x | 15.53% |
| Divi's Laboratories Limited | Rs 9,165 | Rs 2,42,873 Cr | Rs 11,682 Cr | Rs 2,925 Cr | 83.16x | 18.44% |
| Torrent Pharmaceuticals Limited | Rs 4,965.5 | Rs 1,68,062 Cr | Rs 15,654 Cr | Rs 2,156 Cr | 79.32x | 27.30% |
| Zydus Lifesciences Limited | Rs 1,167.8 | Rs 1,16,546 Cr | Rs 29,052 Cr | Rs 4,593 Cr | 26.03x | 17.68% |
| Cipla Limited | Rs 1,423 | Rs 1,14,957 Cr | Rs 29,159 Cr | Rs 3,356 Cr | 34.09x | 10.27% |
| Laurus Labs Limited | Rs 1,861.6 | Rs 1,00,573 Cr | Rs 7,323 Cr | Rs 1,091 Cr | 91.89x | 22.38% |
| Lupin Limited | Rs 2,153 | Rs 98,446 Cr | Rs 30,442 Cr | Rs 5,551 Cr | 17.79x | 27.89% |
| Dr. Reddy's Laboratories Limited | Rs 1,171 | Rs 97,779 Cr | Rs 34,651 Cr | Rs 3,183 Cr | 30.27x | 9.02% |
| Mankind Pharma Limited | Rs 2,356.5 | Rs 97,323 Cr | Rs 15,062 Cr | Rs 2,068 Cr | 47.62x | 13.50% |
| Aurobindo Pharma LimitedThis company | Rs 1,683.3 | Rs 96,857 Cr | Rs 35,625 Cr | Rs 3,711 Cr | 26.30x | 10.53% |
| Glenmark Pharmaceuticals Limited | Rs 2,470.4 | Rs 69,715 Cr | Rs 18,236 Cr | Rs 1,798 Cr | 38.78x | 15.46% |
| Biocon Limited | Rs 401.05 | Rs 65,355 Cr | Rs 17,638 Cr | Rs 416 Cr | — | 1.78% |
| Alkem Laboratories Limited | Rs 5,300 | Rs 63,362 Cr | Rs 15,681 Cr | Rs 2,204 Cr | 29.37x | 16.72% |
| Abbott India Limited | Rs 26,135 | Rs 55,537 Cr | Rs 7,295 Cr | Rs 1,615 Cr | 34.39x | 35.85% |
| GlaxoSmithKline Pharmaceuticals Limited | Rs 2,996.1 | Rs 50,757 Cr | Rs 4,100 Cr | Rs 1,068 Cr | 48.32x | 50.64% |
| Median | Rs 2,153 | Rs 98,446 Cr | Rs 15,681 Cr | Rs 2,925 Cr | 34.39x | 17.68% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.